Tong Ren Tang Technologies Co. Ltd. announced its unaudited interim results for the six months ended 30 June 2025. The Group's revenue for this period was RMB 3.738 billion, marking a decrease of approximately 7.69% from RMB 4.050 billion for the same period in 2024. The profit attributable to owners of the Company was RMB 484 million, reflecting a decline of approximately 21.01% compared to RMB 582 million in the previous year. Earnings per share for the period were reported at RMB 0.26, down from RMB 0.33 in 2024. The Board has decided not to declare an interim dividend for the period ended 30 June 2025. The Company, involved in the manufacturing, retail, and wholesale of Chinese medicine products and healthcare products, continues its operations without any reported changes in business strategy or significant operational updates.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tong Ren Tang Technologies Co. Ltd. published the original content used to generate this news brief on September 11, 2025, and is solely responsible for the information contained therein.
Comments